Bay City Capital Invests in Series D Preferred Stock of Nabsys, Inc.

Represented Bay City Capital in connection with its investment in Nabsys, Inc.

Nabsys is dedicated to enabling advances in life sciences and healthcare through strategic deployment of a novel positional sequencing platform with broad applicability for DNA analysis.